Dexamethasone Elixir — Class II drug recall D-0713-2022
Terminated recall by Morton Grove Pharmaceuticals, Inc., reported 2022-03-09, distributed nationwide. Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found
| Recall number | D-0713-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Morton Grove Pharmaceuticals, Inc., Morton Grove, IL, United States |
| Recall initiated | 2022-02-21 |
| Classified | 2022-03-21 |
| Reported by FDA | 2022-03-09 |
| Terminated | 2024-08-06 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 60432-0466-08 |
| Lot numbers | 1/23, 6/22, 7/23, UV1004, UV1005, UW1014, UW1015, UW1084 |
Product
Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.
Reason for recall
Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0713-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.